近19個交易日累漲126.91% 誠邁科技(300598.SZ)提示風險
格隆匯11月4日丨誠邁科技(300598.SZ)公佈,公司近期在公司現有經營業務未發生重大變化的情況下,股價漲幅較大。截至2019年11月1日收盤,公司股價較2019年9月30日收盤上漲126.91%,同期創業板綜指上漲2.61%;公司目前動態市盈率924.09,而公司所屬軟件服務行業平均為207.59(數據來源於東方財富網)。公司股價近期漲幅顯著超過創業板綜指,市盈率顯著高於行業平均值。公司稱沒有直接參與華為鴻蒙系統的建設及核心技術研發,也沒有提供操作系統供華為公司相關產品使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.